Application of gene therapy to treat age-related loss of dopamine D2 receptor.

Ingram, D K; Ikari, H; Umegaki, H; Chernak, J M; Roth, G S

Ingram, D K; Ikari, H; Umegaki, H; Chernak, J M; Roth, G S.

Affiliation

Ingram DK; Molecular Physiology and Genetics Section, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA. doni@vax.grc.nia.nih.gov

Exp Gerontol ; 33(7-8): 793-804, 1998.

Article in En | MEDLINE | ID: mdl-9951623

Subject(s)

Aging/metabolism; Genetic Therapy; Receptors, Dopamine D2/metabolism; Animals; Feasibility Studies; Mice; Mice, Knockout/genetics; Mice, Knockout/physiology; Rats; Rats, Inbred F344/metabolism; Rats, Sprague-Dawley/metabolism; Receptors, Dopamine D2/genetics; Time Factors

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Aging / Genetic Therapy / Receptors, Dopamine D2 Limits: Animals Language: En Journal: Exp Gerontol Year: 1998 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links